Akari Therapeutics Plc buy krebskrebs
Start price
02.04.24
/
50%
€1.35
Target price
02.04.25
€2.20
Performance (%)
128.15%
Price
14.08.24
€3.08
Summary
This prediction is currently active. The BUY prediction by krebskrebs for Akari Therapeutics Plc has seen massive gains of 128.15%. This prediction currently runs until 02.04.25. The prediction end date can be changed by krebskrebs at any time. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akari Therapeutics Plc | 0.000% | 0.000% |
iShares Core DAX® | 2.722% | -4.863% |
iShares Nasdaq 100 | 4.546% | -7.240% |
iShares Nikkei 225® | 6.353% | -6.674% |
iShares S&P 500 | 3.194% | -3.832% |
Comments by krebskrebs for this prediction
In the thread Akari Therapeutics Plc diskutieren
Buy mit Kursziel 2,2